The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis


Sertpoyraz F. M., Çolak A., Dikici A., Erdinç Gündüz N., Zeytinli Akşit M.

NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI, vol.8, no.1, pp.42-48, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.14744/nci.2020.23590
  • Journal Name: NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.42-48
  • Keywords: Ankylosing spondylitis, disease activity, ischemia-modified albumin, OXIDATIVE STRESS, BONE TURNOVER, INFLAMMATION, BIOMARKER, MARKER
  • Dokuz Eylül University Affiliated: Yes

Abstract

OBJECTIVE: Recent studies have implicated increased oxidative stress in the pathogenesis of Ankylosing spondylitis (AS). Ischemia-modified albumin (IMA), an altered form of albumin, increases oxidative stress. This study aimed to investigate the relationship between IMA levels and other indicators of disease severity in AS.